InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Kerr Douglas, Chief Medical Officer. Officer active across 2 companies, notably Dyne Therapeutics, Inc.. Aggregated, 20 disclosures have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €158k. Activity tracked since 8 July 2021. The latest transaction was filed on 13 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kerr Douglas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
1,556 shares@ US$26.280.0009% mcap16.6% of flowCommon StockSEC:0001814189-26-000004:0
887 sharesCommon StockSEC:0001814189-26-000002:0
1,564 shares@ US$18.360.0009% mcap50.0% of flowCommon StockSEC:0001193125-26-223966:0
904 shares@ US$14.909.4% of flowCommon StockSEC:0001193125-26-096517:0
85,000 shares0Common StockSEC:0001193125-26-055070:0
880 shares@ US$20.7214.1% of flowCommon StockSEC:0001193125-25-309641:0
3,552 shares@ US$13.2742.3% of flowCommon StockSEC:0000950170-25-113538:0
1,342 shares@ US$13.3528.4% of flowCommon StockSEC:0000950170-25-083048:0
1,343 shares@ US$11.8323.4% of flowCommon StockSEC:0000950170-25-035499:0
48,000 shares0Common StockSEC:0000950170-24-134073:0
47,500 shares0Common StockSEC:0000950170-24-103037:0
5,021 sharesCommon StockSEC:0001415889-24-002073:0
7,437 sharesCommon StockSEC:0001415889-24-001334:0
7,437 sharesCommon StockSEC:0001415889-23-014357:0
7,437 sharesCommon StockSEC:0001415889-23-011232:0
7,437 sharesCommon StockSEC:0001415889-23-006595:0
7,438 sharesCommon StockSEC:0001415889-23-001072:0
7,438 sharesCommon StockSEC:0001415889-22-010645:0
14,876 sharesCommon StockSEC:0001415889-22-007766:0
3,518 shares@ US$5.16100.0% of flowCommon StockSEC:0001415889-21-003583:0
20 of 20 declarations
About Kerr Douglas
Kerr Douglas is Chief Medical Officer at Dyne Therapeutics, Inc. and CHIEF MEDICAL OFFICER at Generation Bio Co. He has 19 filings in total, and across the sampled recent filings, the transactions cover the period from 2021-07-12 to 2026-06-17, with EUR 0 of buys and EUR 122773 of sales; the modal transaction nature is Levée d'options.
